Barry J. Simon, Director at ImmunityBio, Inc. (IBRX), sold 346,026 shares at $9.25 ($3.5M) on 2026-02-20, disclosed to the SEC on 2026-02-24.
Open-market sale of $3.5M IBRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.25 | 10,000 | $93K | 2.6% |
| 2 | $8.70 | 6,026 | $52K | 1.5% |
| 3 | $10.25 | 165,000 | $1.7M | 47.9% |
| 4 | $10.25 | 165,000 | $1.7M | 47.9% |
| Total | $10.19 avg | 346,026 | $3.5M | 100% |
| Filing → |
| IBRX | SELL | 2026-06-05 | $165K | — | Filing → |
| IBRX | SELL | 2026-02-26 | $1.8M | — | Filing → |
| IBRX | SELL | 2026-01-21 | $1.1M | — | Filing → |